Cellular and molecular mediators of lymphangiogenesis in inflammatory bowel disease.
Dickson Kofi Wiredu OcanseyBing PeiXinwei XuLu ZhangChinasa Valerie OlovoFei MaoPublished in: Journal of translational medicine (2021)
The effective target of lymphangiogenesis is expected to provide novel therapeutic interventions for intestinal inflammatory conditions, including IBD, through both immune and non-immune cells and based on cellular and molecular mechanisms of lymphangiogenesis that facilitate inflammation resolution.